Covered recipient · General Payments record
BRYCE J CASTEIGNE
Allopathic & Osteopathic Physicians Psychiatry & Neurology Vascular Neurology
General Payments · PY2024
$352.89
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $352.89 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $47.37 | 2 |
| Teva Pharmaceuticals USA, Inc. | $40.53 | 2 |
| ABBVIE INC. | $30.10 | 2 |
| Biogen, Inc. | $30.00 | 1 |
| Merz Pharmaceuticals, LLC | $28.20 | 1 |
| Lundbeck LLC | $26.43 | 1 |
| Neurelis, Inc. | $26.43 | 1 |
| Neurocrine BioSciences, Inc. | $22.50 | 1 |
| ARGENX US, INC. | $21.77 | 1 |
| Otsuka America Pharmaceutical, Inc. | $21.69 | 1 |
| CSL Behring | $20.56 | 1 |
| UCB, Inc. | $19.02 | 1 |
| PFIZER INC. | $18.29 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2024 | $352.89 | 16 |
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.83 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103426850 | CMS |
| ABBVIE INC. | $15.27 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103426852 | CMS |
| Amgen Inc. | $21.76 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111544067 | CMS |
| Amgen Inc. | $25.61 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111544069 | CMS |
| ARGENX US, INC. | $21.77 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142118055 | CMS |
| Biogen, Inc. | $30.00 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104874544 | CMS |
| CSL Behring | $20.56 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134614209 | CMS |
| Lundbeck LLC | $26.43 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145903278 | CMS |
| Merz Pharmaceuticals, LLC | $28.20 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137947474 | CMS |
| Neurelis, Inc. | $26.43 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145636849 | CMS |
| Neurocrine Biosciences, Inc. | $22.50 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150848954 | CMS |
| Otsuka America Pharmaceutical, Inc. | $21.69 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118872380 | CMS |
| PFIZER INC. | $18.29 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131525785 | CMS |
| Teva Pharmaceuticals USA, Inc. | $17.30 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151609922 | CMS |
| Teva Pharmaceuticals USA, Inc. | $23.23 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151609904 | CMS |
| UCB, Inc. | $19.02 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143050755 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2024
- Source files
- Dataset page · Bulk file · PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.